ON-01
AXP000138.1 · Oncolytic virus
- Platform
- HSV-1 (cytosine deaminase-armed)
- Originator
- Beijing Neurosurgical Institute
- Sponsor
- Beijing Neurosurgical Institute
Names
| Name | Type | Source |
|---|---|---|
| ON-01 ambiguous | preferred name, code | curator, ctgov |
Virus
- Role
- Oncolytic
- Family
- Orthoherpesviridae
- Virus
- herpes simplex virus 1 (NCBI Taxonomy 10298)
- Replication
- conditionally replicating
- Modifications
- engineered HSV-1 carrying a cytosine deaminase gene, used with flucytosine
- Transgenes
- cytosine deaminase (CD)
- Route
- intracerebral
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (1)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT06562621 | Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma | Completed | Phase 1/2 | 2018-08-01 | 2022-08-01 | 38 | Glioblastoma Multiforme; Gliomas, Malignant |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41527280 | ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study. | Neuro-oncology | 2026 | name in title: ON-01 |
Notes
Engineered oncolytic HSV-1 carrying a cytosine deaminase (CD) gene, given with flucytosine (5-FC, listed as 'ONF') in recurrent malignant glioma: phase 1/2 NCT06562621 at Beijing Tiantan Hospital, shown as completed. Backbone deletions are not described in the registration.
How to cite
ON-01 (AXP000138.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000138.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.